Cystathionine-β-synthase is essential for AKT-induced senescence and suppresses the development of gastric cancers with PI3K/AKT activation — Haoran Zhu (2021) | RDL Network
Cystathionine-β-synthase is essential for AKT-induced senescence and suppresses the development of gastric cancers with PI3K/AKT activation
Preprint 2021 en
Authors
HZ
Haoran Zhu
KC
Keefe T. Chan
XH
Xinran Huang
Abstract
1 min read
Abstract Hyperactivation of oncogenic pathways downstream of RAS and PI3K/AKT in normal cells induces a senescence-like phenotype that acts as a tumor-suppressive mechanism that must be overcome during transformation. We previously demonstrated that AKT-induced senescence (AIS) is associated with profound transcriptional and metabolic changes. Here, we demonstrate that human fibroblasts undergoing AIS display increased Cystathionine-β-synthase (CBS) expression and consequent activation of the transsulfuration pathway controlling hydrogen sulfide (H2S) and glutathione (GSH) metabolism. Activated transsulfuration pathway during AIS maintenance enhances the antioxidant capacity, protecting senescent cells from ROS-induced cell death via GSH and H2S. Importantly, CBS depletion allows cells that have undergone AIS to escape senescence and re-enter the cell cycle, indicating the importance of CBS activity in maintaining AIS. Mechanistically, we show this restoration of proliferation is mediated through suppressing mitochondrial respiration and reactive oxygen species (ROS) production and increasing GSH metabolism. These findings implicate a potential tumor-suppressive role for CBS in cells with inappropriately activated PI3K/AKT signaling. Consistent with this concept, in human gastric cancer cells with activated PI3K/AKT signaling, we demonstrate that CBS expression is suppressed due to promoter hypermethylation. CBS loss cooperates with activated PI3K/AKT signaling in promoting anchorage-independent growth of gastric epithelial cells, while CBS restoration suppresses the growth of gastric tumors in vivo . Taken together, we find that CBS is a novel regulator of AIS and a potential tumor suppressor in PI3K/AKT-driven gastric cancers, providing a new exploitable metabolic vulnerability in these cancers.
Haoran Zhu, Keefe T. Chan, Xinran Huang, Carmelo Cerra, Shaun Blake, Anna Trigos, Dovile Anderson, Darren J. Creek, David P. De Souza, Xi Wang, Caiyun Fu, Metta Jana, Elaine Sanij, Richard B. Pearson, Jian Jian Kang
Haoran Zhu, Keefe T. Chan, Xinran Huang, Carmelo Cerra, Shaun Blake, Anna Trigos, Dovile Anderson, Darren J. Creek, David P. De Souza, Xi Wang, Caiyun Fu, Metta Jana, Elaine Sanij, Richard B. Pearson, Jian Jian Kang
Keefe T. Chan, Shaun Blake, Haoran Zhu, Jian Jian Kang, Anna Trigos, Piyush B. Madhamshettiwar, Jeannine Diesch, Lassi Paavolainen, Péter Horváth, Ross D. Hannan, Amee J. George, Elaine Sanij, Katherine M. Hannan, Kaylene J. Simpson, Richard B. Pearson
Discussion(0)
No comments yet. Be the first to comment.